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Serotonin (5-hydroxytryptamine, 5-HT) is an ancient
and conserved neuromodulator of energy balance.
Despite its importance, the neural circuits and
molecular mechanisms underlying 5-HT-mediated
control of body fat remain poorly understood. Here,
we decipher the serotonergic neural circuit for body
fat loss in C. elegans and show that the effects of
5-HT require signaling from octopamine, the inverte-
brate analog of adrenaline, to sustain body fat loss.
Our results provide a potential molecular explanation
for the long-observed potent effects of combined
serotonergic and adrenergic weight loss drugs. In
metabolic tissues, we find that the conserved regula-
tory adipocyte triglyceride lipase ATGL-1 drives
serotonergic fat loss. We show that the serotonergic
chloride channel MOD-1 relays a long-range endo-
crine signal from C. elegans body cavity neurons to
control distal ATGL-1 function, via the nuclear recep-
tor NHR-76. Our findings establish a conserved neu-
roendocrine axis operated by neural serotonergic
and adrenergic-like signaling to regulate body fat.
INTRODUCTION
The central nervous system is a major regulator of systemic fat
loss and energy balance. Across different species, genes func-
tioning solely in the central nervous system have been shown
to control body fat and energy expenditure, independent of
effects on food intake (Greer et al., 2008; Kong et al., 2012; Liu
et al., 2012; Lu et al., 2011). Identifying regulators of neural path-
ways that alter body fat without amultitude of other physiological
effects have been difficult to disentangle in mammalian systems.
Thus, it has been challenging to address the fundamental ques-
tion of whether systemic changes in body fat result from long-
range endocrine signals communicated directly by the nervous
system.
The neuromodulator serotonin (5-hydroxytryptamine, 5-HT) is
a conserved regulator of energy balance, and 5-HT signaling672 Cell Metabolism 18, 672–684, November 5, 2013 ª2013 Elsevierserves as an important paradigm for the study of neural regula-
tors of body fat. In mice, loss of the 5HT2c receptor expressed
in the central nervous system leads to adult-onset obesity (Non-
ogaki et al., 2003). In humans, increased neural serotonergic
signaling via pharmacological intervention decreases body fat
and increases energy expenditure in obese subjects (Chan
et al., 2013; Wise, 1992). Interestingly, however, combined neu-
ral serotonergic and adrenergic stimulation has more potent
effects on fat loss compared to 5-HT-based treatments alone
(Fangha¨nel et al., 2000). The mechanisms underlying this effect
remain poorly understood. In the nematode C. elegans, 5-HT
controls many food-related behaviors and physiological out-
puts, including body fat and energy expenditure (Srinivasan
et al., 2008; Sze et al., 2000). 5-HT is synthesized by the
conserved rate-limiting enzyme tryptophan hydroxylase
(tph-1), which is expressed in only a few neurons and, unlike
mammals, is not found in the gut or other fat storage tissues
(Gershon, 2013; Yadav et al., 2008). In the ADF chemosensory
neuron pair that receives and transduces environmental signals,
5-HT synthesis is finely tuned to food availability: short-term
food deprivation decreases tph-1 expression in the ADF neu-
rons, whereas animals reintroduced to food restore tph-1
expression back to that of well-fed animals (Cunningham
et al., 2012). Genes regulating many aspects of 5-HT-mediated
behavior and physiology have been identified, allowing the
dissection of genetic pathways that control various 5-HT-regu-
lated behaviors (Chase and Koelle, 2007). In previous work,
we showed that the potent effects of 5-HT signaling on body
fat are independent of its other physiological effects, including
food intake, locomotion, reproduction, and stress response (Sri-
nivasan et al., 2008). Loss of 5-HT production leads to increased
body fat despite reduced food intake, whereas pharmacologi-
cally induced 5-HT signaling stimulates fat loss and energy
expenditure despite increased food intake. Thus, 5-HT-medi-
ated control of body fat is dissociable from food intake. Three
G protein-coupled receptors (GPCRs) coordinately control
5-HT-mediated food intake and are required in distinct sensory
and pharyngeal neural circuits to control different aspects of
5-HT-mediated feeding behavior (Cunningham et al., 2012;
Song and Avery, 2012). In contrast, a single 5-HT-gated chloride
channel called MOD-1 controls fat loss without altering
5-HT-mediated effects on food intake. 5-HT signaling also re-
quires key fat oxidation genes in metabolic tissues to promoteInc.
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2008).
Despite the importance of 5-HT signaling in the control of body
fat, many questions remain. First, the neural mechanisms gov-
erning 5-HT synthesis and signaling with respect to fat loss
have not been studied, and the extent to which 5-HT functions
in concert with other neuromodulators remains unknown. Sec-
ond, the site of MOD-1 action is not known. Defining the site of
MOD-1 action will answer the critical question of whether 5-HT
itself functions as a long-range neuroendocrine signal or whether
5-HT signaling in the nervous system leads to the release of
downstream effectors which in turn act as neuroendocrine sig-
nals. Third, in metabolic tissues where fat stores are mobilized,
the intracellular regulatory pathways that must be activated to
stimulate 5-HT-mediated fat oxidation remain unknown. The
C. elegans model system is well suited to address questions in
neuroendocrine biology. In recent years, studies of C. elegans
fat regulatory pathways have revealed extensive conservation
of function between organisms as diverse as mammals and
nematodes (Jones et al., 2009; Mak, 2012; Narasimhan et al.,
2011; O’Rourke et al., 2013; Perez and Van Gilst, 2008; Walker
et al., 2011), suggesting conserved principles of energy regula-
tion across metazoans.
In the present study, we begin by describing the neural circuit
underlying 5-HT-mediated fat loss in C. elegans. We show that
5-HT-mediated fat loss requires octopamine (Oct, the inverte-
brate analog of adrenaline) via the biosynthetic enzyme tyramine
beta-hydroxylase (tbh-1), that Oct signaling, in turn, modulates
the expression of the 5-HT biosynthesis enzyme tryptophan hy-
droxylase (tph-1), and that combined 5-HT and Oct administra-
tion leads to a synergistic loss of body fat. Thus, 5-HT and Oct
function together in a positive regulatory loop to sustain a neural
signal for body fat loss. We define the site ofmod-1 function to a
unique pair ofC. elegans neurons called the URX neurons, which
have access to the circulatory fluid. The anatomy of the URX
body cavity neurons allows for a functional basis for studies of
molecular communication between the nervous system and
metabolic tissues. In the intestine where body fat is stored, we
found that the conserved regulatory adipocyte triglyceride lipase
atgl-1 drives 5-HT-dependent fat loss. Finally, we show that the
serotonergic neural circuit relays a long-range instructive signal
via the URX neurons to control intestinal atgl-1 transcriptional
levels and that this signaling pathway requires an intestinal
nuclear receptor called nhr-76. Together, our studies describe
a serotonergic and adrenergic-like neuroendocrine signaling
pathway that controls body fat in C. elegans.
RESULTS
5-HT Signaling Requires Neural Oct to Elicit Fat Loss
To expand our knowledge of 5-HT-mediated fat loss, we began
by testing the roles of several candidate genes. We focused on
the major biogenic amine signaling pathways because they
have been implicated in modulating 5-HT signaling in metazoans
(Nonogaki, 2000; Yadav et al., 2009). In our candidate screen, we
observed that tyramine beta-hydroxylase tbh-1(n3247) mutants
suppress the fat loss elicited by exogenous 5-HT. As observed
previously, 5-HT-treated wild-type animals have approximately
40%of the fat of vehicle-treated animals, whereas tbh-1mutantsCell Mretain60% of the fat of vehicle-treated animals (Figures 1A and
1B and Table S1 available online), as judged by oil red O staining
and by quantitation of biochemically extracted triglycerides
(Figure S1A). Vehicle-treated tbh-1 mutants do not show a
discernible difference in body fat compared to wild-type animals
(Figures 1A and 1B). TBH-1 is a rate-limiting enzyme that con-
trols Oct biosynthesis in C. elegans; thus, tbh-1 mutants lack
Oct (Alkema et al., 2005). Oct is a catecholamine neurotrans-
mitter that is thought to function as a fight-or-flight stress hor-
mone in insects and is generally regarded as the invertebrate
counterpart to adrenaline (Roeder, 2005). In C. elegans, Oct
and its precursor Tyramine (Tyr) regulate locomotion (Alkema
et al., 2005; Maguire et al., 2011) and feeding behavior (Greer
et al., 2008) in response to stress signals. However, the role of
these neurotransmitters in regulating C. elegans body fat re-
mains unclear. We found that wild-type animals treated with
exogenous Oct had approximately 50% less body fat than
vehicle-treated controls (Figures 1C, 1D, and S1A), whereas
animals treated with the same dose of the closely related Tyr
did not. Thus, octopaminergic or adrenergic-like treatment de-
creases body fat in C. elegans.
We reasoned that if 5-HT-mediated fat loss requires intact Oct
signaling, a downstream octopaminergic GPCR must also be
required. The C. elegans genome contains three octopaminergic
and three closely related tyraminergic GPCRs. We examined
loss-of-function mutants for each of the six GPCRs and found
that only loss of the ser-6GPCR suppressed the fat loss induced
by 5-HT (Figures 1A, 1B, S1B, and S1C), recapitulating previous
studies (Srinivasan et al., 2008). ser-6(tm2146) mutants treated
with 5-HT have a nearly 2-fold-greater proportional increase in
body fat (70%–75%) compared to wild-type animals (35%–
40%; Figures 1A and 1B and Table S1). tbh-1;ser-6 double
mutants resemble tbh-1 and ser-6 single mutants and retain
body fat upon 5-HT treatment to the same extent as either single
mutant alone, providing in vivo evidence that tbh-1 and ser-6
function in a linear pathway (Figures 1A and 1B). Our results
show that 5-HT-induced fat loss requires neural Oct synthesis
via tbh-1 and signaling via the ser-6 octopaminergic receptor.
The Octopaminergic Receptor SER-6 Functions in
AWB Chemosensory Neurons to Control 5-HT-Mediated
Fat Loss
Since ser-6 signaling is required for 5-HT-mediated fat loss, we
wanted to determine its site of action. ser-6 has been character-
ized as a selective Oct receptor (Mills et al., 2012), and tbh-1, the
enzyme that synthesizes Oct, is expressed in a single pair of
interneurons called RIC (Alkema et al., 2005). Therefore, we
examined the C. elegans wiring diagram (White et al., 1986) for
neurons that receive direct synaptic input from RIC (Figure 1E).
A survey of the published literature and examination of our ser-
6-expressing transgenic lines showed that it is expressed across
many C. elegans neurons, including both sensory and interneu-
rons (Mills et al., 2012). Introduction of the ser-6 transgene under
the control of its own promoter fully restored the ability of 5-HT to
elicit fat loss in ser-6(+) transgenic animals, but not in ser-6()
nontransgenic controls (Figures 1F and 1G and Table S2). In
ser-6 mutants, we used the unc-7 promoter to reconstitute
ser-6 function because of its broad expression in neurons that
receive direct synaptic input from RIC (Starich et al., 2009).etabolism 18, 672–684, November 5, 2013 ª2013 Elsevier Inc. 673
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Figure 1. Oct Signaling Is Required for 5-HT-Mediated Fat Loss
(A) Representative images of vehicle-treated (top row) or 5-HT-treated (bottom row) animals fixed and stained with oil red O. Fat deposition in the intestinal cells is
visible as stained lipid droplets (black arrowhead). Animals are oriented facing upward, with the pharynx (white arrowhead) at the anterior end.
(B) Fat content was quantified for each genotype and expressed as a percentage of wild-type animals ± SEM (n = 10–15). tbh-1, ser-6 single mutants and
tbh-1;ser-6 double mutants retain a significantly greater proportion of fat upon 5-HT treatment compared to wild-type animals. Data are expressed as a per-
centage of vehicle-treated wild-type animals ± SEM. **p < 0.005.
(C) Representative images of vehicle-, Oct-, or Tyr-treated animals fixed and stained with oil red O.
(D) Fat content was quantified and expressed as a percentage of wild-type vehicle-treated animals (n = 10–15) ± SEM. **p < 0.005.
(E) Synaptic and gap-junction connections projecting from the RIC interneurons. The promoters used to confer expression in the relevant neurons are as marked.
Arrow lines, synaptic connections; bar lines, gap junctions.
(F) Representative images of vehicle-treated (top row) or 5-HT-treated (bottom row) animals fixed and stainedwith oil red O. For each transgenic line bearing ser-6
expression using the indicated promoter, nontransgenic animals () and transgenic animals (+) are shown. Oil red O staining intensities are given in Table S2.
(G) The proportion of fat retained upon 5-HT treatment relative to vehicle treatment is shown for each genotype (n = 10–15). Relative to nontransgenic controls
(gray bars), ser-6 transgenic animals (black bars) bearing the ser-6 transgene under the control of the endogenous ser-6 and the heterologous str-1 promoters
restore 5-HT-mediated fat loss. Data are expressed as a percentage of vehicle-treated wild-type animals R SEM. **p < 0.005; ns, not significant. See also
Figure S1 and Tables S1 and S2.
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A 5-HT Neuroendocrine Circuit for Body Fat ControlHowever, in ser-6(+) transgenic animals, ser-6 expression under
the control of the unc-7 promoter did not rescue the suppression
of fat loss seen in nontransgenic controls (Figures 1F and 1G).
A closer examination of our ser-6(+) transgenic lines revealed
strong expression of ser-6 in the AWB sensory neurons (Figures
S1D–S1F). We restored ser-6 expression to ser-6mutants solely
in the AWB sensory neurons using the str-1 promoter (Troemel
et al., 1997). We found that 5-HT treatment elicits fat loss in
str-1::ser-6(+) transgenic animals to an extent similar to that
seen with the endogenous ser-6 promoter and wild-type animals
(Figures 1F and 1G). Thus, ser-6 function in AWB olfactory neu-
rons fully rescues 5-HT-mediated fat loss. Additionally, we
wanted to test whether ser-6 modifies another aspect of AWB
function. AWB olfactory neurons control the behavioral avoid-674 Cell Metabolism 18, 672–684, November 5, 2013 ª2013 Elsevierance of a volatile repellent 2-nonanone, and we found that
ser-6 mutants were defective in 2-nonanone avoidance (Fig-
ure S2A), thus corroborating an independent functional role for
ser-6 in AWB neurons.
The ser-6 octopaminergic receptor would also be expected to
suppress the observed Oct-induced fat loss. Accordingly, we
found that ser-6 mutants retain nearly 80% of their body fat
upon Oct treatment (Figures 2A and 2B), compared to50% re-
tained by wild-type animals. Because our ser-6 transgenic
rescue experiments indicated a role for ser-6 in AWB neurons,
we tested whether loss of AWB neurons also modified Oct-
induced fat loss. We generated a transgenic line expressing
tetanus toxin under the control of the AWB-specific str-1 pro-
moter. Transgenic animals in which synaptic signaling fromInc.
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Figure 2. The Octopaminergic ser-6 GPCR in AWB Neurons Controls Serotonergic Functions in ADF Neurons
(A) ser-6, tph-1 single mutants and ser-6;tph-1 double mutants retain a significantly greater proportion of fat upon Oct treatment compared to wild-type animals.
(B) Fat content was quantified for each genotype and expressed as a percentage of wild-type animals ± SEM (n = 10–15). **p < 0.005. The proportion of fat
retained upon 5-HT administration for each genotype is given in Table S1.
(C) Representative images of vehicle-treated (top row) or Oct-treated (bottom row) animals fixed and stained with oil red O. Genotypes are as indicated in the
figure. For the indicated transgenic line bearing tetanus toxin using the str-1 promoter, nontransgenic animals () and transgenic animals (+) are shown.
(D) The proportion of fat retained upon Oct treatment relative to vehicle treatment is shown for transgenic and nontransgenic animals ± SEM (n = 10–15).
**p < 0.005.
(E) Representative images of wild-type (upper panel) and ser-6(tm2146) (lower panel) animals expressing GFP under the control of the tph-1 promoter. tph-1
expression is visible in the NSM (open arrowheads) and in the ADF (dashed arrowheads) neurons. In ser-6 mutants, tph-1 expression in ADF chemosensory
neurons is decreased relative to wild-type animals. The anterior end of the animals is oriented toward the left.
(F) The fluorescence intensity of tph-1 expression in ADF neurons is quantified and expressed relative to wild-type animals ± SEM (n = 30–40). **p < 0.05.
(G) Anti-5-HT immunostaining shows that 5-HT production from ADF chemosensory neurons (dashed arrowheads) is diminished in ser-6 mutants (lower panel)
relative to wild-type (upper panel). See also Figure S2 and Table S1.
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A 5-HT Neuroendocrine Circuit for Body Fat ControlAWB neurons was abolished suppressed Oct-induced fat loss to
the same extent as ser-6mutants (Figures 2C and 2D). We reca-
pitulated this result in the C. elegans lineage mutant lim-4, which
lacks AWB neurons (Sagasti et al., 1999) (Figures S2B and S2C).
AWB neurons receive direct synaptic input from RIC neurons
where Oct is synthesized. Together, our results show that Oct
synthesis via tbh-1 in RIC neurons leads to ser-6-mediated
signaling in AWB neurons and that this activation is required to
mediate both serotonergic and octopaminergic fat loss.
Oct Signaling via SER-6 in AWB Olfactory Neurons
Maintains 5-HT Production
How might Oct regulate 5-HT-mediated fat loss? We noted that
one of the strongest synaptic outputs of the AWB olfactory neu-
rons in which ser-6 expression regulates 5-HT-mediated fat loss
is to the ADF chemosensory neurons (White et al., 1986) (www.
wormweb.org). The ADF neurons are best known for their role
in controlling 5-HT-mediated behaviors via modulation of theCell Mrate-limiting enzyme for 5-HT synthesis, tryptophan hydroxylase
(tph-1, not to be confused with tbh-1). This prompted us to
test whether Oct signaling via ser-6 modifies the 5-HT pathway
by altering some aspect of tph-1 function. We crossed ser-
6(tm2146) mutants into a tph-1::GFP reporter transgenic line
and measured tph-1 expression in ADF neurons. We found
that relative to wild-type animals, loss of ser-6 decreases tph-1
expression in ADF neurons by approximately 25% (Figures 2E
and 2F). Interestingly, anti-5-HT immunostaining revealed that
ser-6 mutants lack 5-HT in ADF neurons (Figure 2G). We note
that lim-4 mutants, which lack AWB neurons (Sagasti et al.,
1999), are reported to have decreased tph-1 expression and
5-HT production in ADF neurons (Zheng et al., 2005). Thus,
ser-6 function in AWB neurons is required to maintain 5-HT syn-
thesis and production in ADF neurons.
A prediction that arises from our observation is that the fat
loss induced by Oct via ser-6 should, at least in part, be depen-
dent on intact 5-HT signaling. We treated tph-1(mg280)mutantsetabolism 18, 672–684, November 5, 2013 ª2013 Elsevier Inc. 675
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Figure 3. tph-1 Expression in ADF Chemosensory Neurons Controls
Fat Loss
(A) Representative images of animals fixed and stained with oil red O. For each
indicated transgenic line bearing tph-1 expression using the indicated pro-
moter, nontransgenic animals () and transgenic animals (+) are shown.
(B) Fat content was quantified for each genotype and expressed as a per-
centage of wild-type animals ± SEM (n = 10–15). Relative to nontransgenic
controls (gray bars), tph-1(+) transgenic animals bearing the tph-1 transgene
under the control of the endogenous tph-1 and the heterologous srh-142
promoters fully restore the increased body fat of tph-1mutants back to wild-
type. **p < 0.005; ns, not significant.
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A 5-HT Neuroendocrine Circuit for Body Fat Controlwith exogenous Oct and observed an approximately 80% reten-
tion of body fat compared to wild-type Oct-treated animals
(50%; Figures 2A and 2B). tph-1 mutants have increased
body fat relative to wild-type animals; however, the proportional
suppression of Oct-induced fat loss is the same as in the ser-6
mutants (80%; see Table S1). The body fat of vehicle-treated
ser-6;tph-1 double mutants resemble tph-1 single mutants and
suppress Oct-induced fat loss to the same extent as either single
mutant alone (Figures 2A and 2B). These results suggest that
tph-1 functions downstream of ser-6 in a linear pathway to sup-
press Oct-induced fat loss. Thus, we find that just as 5-HT
signaling requires Oct production via tbh-1 (Figure 1), Oct
signaling in turn requires 5-HT production via tph-1 (Figure 2).
5-HT from ADF Chemosensory Neurons Regulates
Fat Loss
Our results indicated that the control of tph-1 expression in
ADF neurons might be an important mechanism of 5-HT-medi-
ated fat loss. Relative to wild-type animals, tph-1 mutants have
increased body fat (Figures 3A and 3B). A similar increase in676 Cell Metabolism 18, 672–684, November 5, 2013 ª2013 Elsevierbody fat has been previously noted using Sudan black staining
(Sze et al., 2000) and mass spectrometry (Ashrafi et al., 2003).
tph-1 is expressed in two pairs of neurons in the head of the
animal: the neurosecretory motor (NSM) neurons that have
dendritic endings in the lumen of the pharynx (the feeding organ
for C. elegans) and the ADF chemosensory neurons whose den-
drites project outside the animal (White et al., 1986). We restored
tph-1 expression to either NSM or ADF neurons using the ceh-2
and srh-142 promoters, respectively (Zhang et al., 2005). As ex-
pected, tph-1 expression under the control of its own promoter
fully restored the increased fat content of tph-1(+) transgenic
animals to wild-type levels, relative to tph-1() nontransgenic
animals. We found that transgenic rescue of tph-1 in ADF, but
not NSM neurons, was sufficient to fully restore the increased
fat content of tph-1 mutants back to wild-type (Figures 3A and
3B). In addition to body fat, other food-related behaviors also
stem from tph-1 function in ADF neurons: food intake (Cunning-
ham et al., 2012), olfactory learning (Zhang et al., 2005), and
aerotaxis (Chang et al., 2006). Because tph-1 function in ADF
neurons regulates many diverse phenotypes, we propose that
the control of each serotonergic ADF-mediated behavioral or
metabolic outcome must either employ distinct serotonergic
receptors, distinct neural circuits, or a combination of the two
strategies.
The 5-HT-Gated Chloride Channel MOD-1 Functions in
URX Body Cavity Neurons to Promote Fat Loss
Previous studies have shown that food intake and fat content
are regulated by distinct neurally expressed serotonergic recep-
tors: three GPCRs (ser-1, ser-5, and ser-7) regulate 5-HT-medi-
ated increase in food intake, whereas the 5-HT-gated chloride
channel mod-1 controls fat loss (Cunningham et al., 2012; Srini-
vasan et al., 2008). MOD-1 is activated by direct binding of
5-HT, which functions as its only known ligand (Ranganathan
et al., 2000; Ringstad et al., 2009). We wanted to identify the
neurons in which mod-1 functions to control 5-HT-mediated
fat loss. 5-HT-treated mod-1(ok103) mutants have a 2-fold-
greater proportional increase in body fat (75%–80%) compared
to vehicle-treated controls (Figures 4B and 4C and Table S1);
thus, mod-1 mutants suppress 5-HT-induced fat loss, as
described previously (Srinivasan et al., 2008). Introduction of
the mod-1 transgene under the control of its own promoter fully
restored the ability of 5-HT to elicit fat loss in mod-1(+) trans-
genic animals, but not in mod-1() nontransgenic controls (Fig-
ures 4B and 4C and Table S3). Next, we expressed the mod-1
transgene in the major class of interneurons onto which ADF
synapses: the AIA, AIY, and AIZ neurons (Figure 4A). These neu-
rons regulate forward and backward locomotion and chemo-
sensation in response to a variety of stimuli (Gray et al., 2005).
In addition, all known functions of mod-1 have been associated
with expression in the AIY and AIZ neurons (Ha et al., 2010; Har-
ris et al., 2009; Zhang et al., 2005). To our surprise, mod-1
expression in the AIA, AIY, and AIZ neurons using the canonical
ttx-3 promoter did not rescue the suppression of 5-HT-medi-
ated fat loss in mod-1 mutants (Figures 4B and 4C). We verified
these results by generating independent transgenic lines
bearing the mod-1 transgene under the control of the flp-1
promoter, which allows expression in the RIG, AIA, and AIY
neurons, and obtained similar results. Thus, the control ofInc.
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Figure 4. The mod-1 Chloride Channel Functions in URX Body Cavity Neurons to Control 5-HT-Mediated Fat Loss
(A) Synaptic and gap-junction connections projecting from the ADF chemosensory neurons are shown. The promoters used to confer expression in the relevant
neurons are as marked. Arrow lines, synaptic connections; bar lines, gap junctions.
(B) Representative images of vehicle (top row) or 5-HT (bottom row) animals fixed and stained with oil red O. For each transgenic line bearingmod-1 expression
using the indicated promoter, nontransgenic animals () and transgenic animals (+) are shown.
(C) The proportion of fat retained upon 5-HT treatment relative to vehicle treatment is shown for each genotype (n = 10–15). Relative to nontransgenic controls
(gray bars), mod-1 transgenic animals (black bars) bearing the mod-1 transgene under the control of the endogenous mod-1 and the heterologous gcy-36 and
flp-8 promoters restore 5-HT-mediated fat loss. Data are expressed as a percentage of vehicle-treated wild-type animals ± SEM. **p < 0.005; ns, not significant.
See also Figure S3 and Table S3.
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A 5-HT Neuroendocrine Circuit for Body Fat Control5-HT-mediated fat loss by mod-1 must employ a set of neurons
distinct from those used in other behaviors.
Visual inspection of the C. elegans wiring diagram revealed
that ADF neurons synapse onto the URX pair of body cavity neu-
rons (www.wormweb.org). These neurons are best known for
their role in oxygen sensation (Gray et al., 2004) and, more
recently, for the control of body size (Mok et al., 2011). The
URX neurons receive synaptic input frommany sensory neurons
and, importantly, are anatomically positioned to access the
coelomic fluid that functions as the circulatory system for
C. elegans (White et al., 1986). We restored mod-1 expression
in URX neurons using two well-established promoters: the gcy-
36 promoter, which also confers expression in the AQR and
PQR body cavity neurons, and the flp-8 promoter, which is ex-
pressed strongly in the URX neurons and sporadically in the
AUA interneurons (Cheung et al., 2005; Gray et al., 2004) (Fig-
ure 4A). In both sets of transgenic animals in which mod-1
expression had been restored to URX neurons, we observed
rescue of 5-HT-induced fat loss (Figures 4B and 4C). To verifyCell Mthat mod-1 is endogenously expressed in URX neurons, we re-
examined transgenic lines in which mod-1 is controlled by its
own promoter. We observed expression of mod-1 in neurons,
consistent with the position and structural anatomy of URX neu-
rons (Figure S3). Thus, our results show that the 5-HT-gated
chloride channel mod-1 functions in the URX body cavity neu-
rons to control 5-HT-mediated fat loss.
Synergistic Effects of Combined 5-HT and Oct
Administration
Thus far, our studies of the serotonergic neural circuit predict a
linear pathway that connects the synthesis of Oct in RIC
interneurons and the ser-6 octopaminergic GPCR in AWB
olfactory neurons to the synthesis of 5-HT in ADF chemosen-
sory neurons and mod-1 function in the URX body cavity neu-
rons. However, multiple lines of evidence indicate a positive
regulatory relationship between 5-HT and Oct signaling. First,
Oct pathway genes tbh-1 and ser-6 regulate 5-HT-mediated
fat loss (Figure 1), and 5-HT pathway genes tph-1 and mod-1etabolism 18, 672–684, November 5, 2013 ª2013 Elsevier Inc. 677
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Figure 5. Synergistic Effects of Combined 5-HT and Oct Treatment
(A) Representative images of vehicle-treated (left panels), 5-HT-treated (center panels), and Oct-treated (right panels) animals fixed and stained with oil red O.
(B) Fat content was quantified for each genotype and expressed as a percentage of wild-type animals ± SEM (n = 10–15). Upon either 5-HT (dark gray bars) or Oct
(light gray bars) administration, mod-1;ser-6 double mutants retain a greater proportion of fat than either mod-1 or ser-6 mutants alone.
(C) Representative images of vehicle-treated (left panels), 5-HT-treated (center panels), and Oct-treated (right panels) animals fixed and stained with
oil red O.
(D) Fat content was quantified for each genotype and expressed as a percentage of wild-type animals ± SEM (n = 10–15). Combined 5-HT and Oct treatment was
administered at half the dose (2.5mM each; white bar). In all panels, data are expressed as a percentage of vehicle-treated wild-type animals ± SEM. ***p < 0.005,
**p < 0.05. See also Table S1.
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A 5-HT Neuroendocrine Circuit for Body Fat Controlregulate Oct-mediated fat loss (Figures 2, 5A, and 5B). Second,
ser-6 and the AWB neurons regulate 5-HT production in ADF
neurons (Figure 2), which control serotonergic fat loss (Figure 3).
Third, we found that upon either 5-HT or Oct administration,
mod-1;ser-6 double mutants have a greater proportion of
body fat (100% compared to 75%) than either single mutant
alone (Figures 5A and 5B and Table S1). Thus, whereas mod-1
and ser-6 single mutants function as partial suppressors of
5-HT- and Oct-induced fat loss, and vehicle-treated mutant
animals have no overt change in body fat, mod-1;ser-6 double
mutants fully suppress the fat loss induced by either 5-HT or
Oct, and vehicle-treated animals have an approximate 10%
increase in body fat (Figures 5A and 5B). Finally, we found
that wild-type animals simultaneously administered low doses
(2.5 mM) of 5-HT and Oct show a greater decrease in body
fat compared to double the dose (5 mM) of either 5-HT or
Oct alone (Figures 5C and 5D). Interestingly, the URX neurons
in which mod-1 regulates serotonergic fat loss also form a
direct synaptic connection to the RIC neurons in which the
enzyme TBH-1 synthesizes Oct. Together, our analysis de-
scribes an integrated neurotransmitter circuit in which 5-HT
and Oct pathways in the nervous system regulate one another
in a positive regulatory loop and coordinately control distal
body fat loss. Given the unique anatomy of URX neurons, our
results provide a structural and functional basis for communi-
cation between the nervous system and the metabolic tissues
where body fat is stored.678 Cell Metabolism 18, 672–684, November 5, 2013 ª2013 ElsevierC. elegans ATGL Regulates 5-HT-Mediated Lipolysis in
Metabolic Tissues
Lipases are a family of enzymes that are rate limiting for the gen-
eration of free fatty acids via lipid hydrolysis. Fatty acids are then
targeted for oxidation and the production of energy in metabolic
tissues. Because previous studies had shown that the 5-HT
signaling pathway stimulates lipid hydrolysis and increases
energy expenditure (Srinivasan et al., 2008), we reasoned that
one or more lipases may function as upstream regulators that
generate free fatty acids from stored lipids. The C. elegans
genome contains 100 genes containing the conserved lipase
domain that includes the Ser-His-Asp/Glu catalytic triad charac-
teristic of this family of enzymes. We screened all the genes
for which RNAi clones were available from the C. elegans
genome-wide libraries to identify the lipase(s) essential for
5-HT-mediated fat loss. We observed the strongest effect
upon depletion of C05D11.7/atgl-1, the sole C. elegans ortholog
of adipocyte triglyceride lipase (ATGL). As expected, 5-HT-
treated wild-type animals have approximately 35%–40% of the
fat of untreated animals, whereas atgl-1-inactivated animals
retain nearly all of the fat compared to untreated animals (Figures
6A and 6B), suggesting that loss of atgl-1 leads to near-complete
suppression of 5-HT-mediated fat loss. Other well-conserved
C. elegans lipase orthologs, including hormone-sensitive lipase,
diacylglycerol lipase, and gastric lipase, were not essential for
5-HT-mediated fat loss (data not shown). In mammals, ATGL is
expressed in several tissues in which fat is mobilized uponInc.
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Figure 6. The Conserved Triglyceride Lipase atgl-1 and the Nuclear Receptor nhr-76 Control 5-HT-Mediated Fat Loss in the Intestine
(A) Representative images of vehicle (top row) or 5-HT (bottom row) animals fixed and stained with oil red O.
(B) The proportion of fat retained upon 5-HT treatment relative to vehicle treatment is shown for each condition (n = 10–15). Data are expressed as a percentage of
vehicle-treated wild-type animals ± SEM. **p < 0.005.
(C) Images of wild-type animals bearing an integrated atgl-1::GFP transgene exposed to vehicle (upper left panel) or 5-HT (lower left panel), compared to nhr-76-
inactivated animals exposed to vehicle (upper right panel) or 5-HT (lower right panel). Inset: magnified view of the region (third and fourth pairs of intestinal cells)
used for quantification.
(D) The fluorescence intensity of atgl-1 expression is quantified (see inset in C) and expressed relative to control-treated animals ± SEM (n = 20–30). Black bars,
vehicle treatment; gray bars, 5-HT treatment. **p < 0.005. See also Figure S4 and Table S1.
(E) Representative images of vehicle (top row) or 5-HT (bottom row) animals fixed and stained with oil red O. The proportion of fat retained upon 5-HT treatment
relative to vehicle treatment is shown for each condition (n = 10–15). Data are expressed as a percentage of vehicle-treated wild-type animals ± SEM. **p < 0.005.
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A 5-HT Neuroendocrine Circuit for Body Fat Controlenergy demand, and is the rate-limiting enzyme for triglyceride
hydrolysis (Zimmermann et al., 2004). As expected for a lipase
that controls body fat loss, we observed strong atgl-1 expression
in the intestine, themajor body fat depot inC. elegans (Figure 6C).
Interestingly, upon addition of exogenous 5-HT, we observed an
approximately 40% induction of GFP expression in the intestine
(Figures 6C and 6D), suggesting that the atgl-1 promoter is tran-
scriptionally induced by 5-HT. To corroborate our experiments
using the atgl-1 reporter line, we conducted quantitative PCR
(qPCR) studies and found an approximately 1.5-fold increase
in atgl-1 expression upon 5-HT treatment (Figure S4A). Oct treat-
ment alone did not induce GFP expression in the atgl-1 reporter
line (Figure S4B).
The Nuclear Receptor NHR-76 Regulates 5-HT-
Mediated Induction of ATGL
In vitro studies have identified transcriptional regulators of
mammalian ATGL expression in cell culture (Chakrabarti
et al., 2011; Kershaw et al., 2007); however, the regulatory con-
trol of ATGL transcription in vivo remains poorly characterized.
We sought to identify transcriptional regulators of atgl-1
expression by taking advantage of the transparent body of
C. elegans in which expression level changes in the atgl-1Cell MGFP reporter can be clearly observed in living animals. In
C. elegans, the nuclear hormone receptor (NHR) family consists
of 280 members, the majority of which are expressed in
metabolic tissues (Arda et al., 2010). Because nuclear hormone
receptors often have endocrine roles in metabolism, and evi-
dence in the literature suggests that nuclear receptors regulate
ATGL in vitro (Kershaw et al., 2007), we screened this family of
transcriptional regulators for suppression of the 5-HT-induced
increase in atgl-1 transcription. We identified nhr-76 as the
sole hit from our RNAi-based nuclear receptor screen: nhr-76
knockdown abrogated the increase in atgl-1 expression seen
in 5-HT-treated animals (Figures 6C and 6D). We also found
that nhr-76 is essential for 5-HT-mediated fat loss (Figures 6E
and 6F). 5-HT-treated animals in which nhr-76 was inactivated
retained a significant proportion of their body fat compared to
vehicle-treated animals (Figures 6E and 6F and Table S1).
Finally, to determine the site of nhr-76 action, we generated a
reporter line in which a 7 kb upstream promoter element was
fused to GFP. We found that nhr-76 is expressed in the
C. elegans intestine, in which atgl-1 is also expressed (Fig-
ure S4C). Thus, we observe that nhr-76 functions as an acti-
vator of 5-HT-mediated atgl-1 transcription in the C. elegans
intestine to control body fat.etabolism 18, 672–684, November 5, 2013 ª2013 Elsevier Inc. 679
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Figure 7. Neural 5-HT Signaling Relays an Instructive Signal to the Intestine to Control atgl-1 Expression
(A) Images of animals bearing the atgl-1::GFP transgene in the wild-type (upper panel) or tph-1 (lower panel) backgrounds. Inset: magnified view of the third and
fourth pairs of intestinal cells. Loss of neural 5-HT signaling via abrogation of tph-1 significantly decreases atgl-1 expression in the intestine.
(B) Fluorescence intensity of atgl-1 expression in the third and fourth intestinal cells is quantified and expressed relative to wild-type animals ± SEM (n = 20).
**p < 0.005.
(C) Images of atgl-1::GFP animals bearing antisense-mediated inactivation of mod-1 in the URX neurons. In nontransgenic animals, 5-HT treatment (relative to
vehicle treatment; upper left panel) induces an increase in atgl-1::GFP expression (lower left panel). In contrast, in transgenic animals in which mod-1 is in-
activated in the URX neurons (white arrowheads), 5-HT treatment no longer elicits an increase in atgl-1 expression (lower right panel), yet it resembles vehicle
treatment (upper right panel). Inset: magnified view of the third and fourth pairs of intestinal cells.
(D) Fluorescence intensity of atgl-1 expression in the third and fourth intestinal cells is quantified and expressed relative to wild-type animals ± SEM (n = 20).
**p < 0.005.
(E) Schematic depiction of the serotonergic neuroendocrine pathway that controls body fat. The described neural circuit for fat loss integrates Oct or adrenaline-
like signaling with 5-HT production and function. 5-HT production in the ADF chemosensory neurons activates the serotonergic chloride channel MOD-1 in the
URX body cavity neurons to elicit fat loss. 5-HT signaling relays a neuroendocrine instructive signal from the nervous system to the distal intestine via unknown
neuroendocrine effectors. In intestinal cells where body fat is stored, activation of the neural circuit leads to increased expression of the conserved lipase atgl-1
via the nuclear receptor nhr-76, which in turn liberates triglycerides and elicits fat loss. See also Figure S5.
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Control ATGL Transcription
Thus far, our genetic studies of the serotonergic fat loss pathway
describe the nhr-76 and atgl-1-mediated regulation of fat loss in
the intestine and an upstream neural circuit that implicates a role
for mod-1 in the URX neurons in releasing signals that are
relayed to the intestine. To explicitly test this hypothesis, we con-
ducted three experiments. First, we tested whether loss of 5-HT
modified atgl-1 expression. We crossed tph-1(mg280) mutants
into the atgl-1 reporter line and found that atgl-1 expression
was decreased to approximately 65% of wild-type (Figures 7A680 Cell Metabolism 18, 672–684, November 5, 2013 ª2013 Elsevierand 7B). Our data show that atgl-1 expression levels and the
concomitant changes in body fat are responsive to both
increased 5-HT signaling and loss of 5-HT. Thus, 5-HT functions
as an instructive neural regulator of body fat via modulation
of atgl-1.
Second, we wished to ascertain whether the loss of mod-1
specifically from the URX neurons modified atgl-1 transcription.
Using antisense technology, we generated transgenic animals
in which mod-1 sense and antisense (SAS) expression were
under the control of the flp-8 promoter, in atgl-1::GFP reporter
animals. Thus, in the mod-1 SAS(+) animals, mod-1 expressionInc.
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A 5-HT Neuroendocrine Circuit for Body Fat Controlis abrogated specifically in the URX neurons. Wemeasured atgl-
1::GFP expression intensity in the C. elegans intestine in trans-
genic and nontransgenic animals treated with vehicle or 5-HT.
As expected, 5-HT treatment increased atgl-1 expression in
mod-1 SAS() nontransgenic animals by approximately 45%.
Transgenic animals bearing the mod-1 SAS(+) constructs in
the URX neurons fully blocked the 5-HT-mediated increase in
atgl-1 expression (Figures 7C and 7D). Upon 5-HT treatment,
the inactivation of nhr-76 did not further decrease atgl-1 expres-
sion inmod-1 SAS(+) transgenic animals (Figure S5A). Finally, we
examined body fat content of animals in which mod-1 was
inactivated in URX neurons and found that 5-HT-mediated fat
loss was suppressed by approximately 50% compared to that
in wild-type animals (Figures S5B and S5C). Our results show
that 5-HT signaling via mod-1 in the URX neurons relays an
instructive endocrine signal that is received by the intestinal
tissue to control atgl-1 expression and body fat via nhr-76
(Figure 7E).
DISCUSSION
In this report, we describe aC. elegans neuroendocrine signaling
pathway that originates in the nervous system and operates via
body cavity neurons to regulate body fat in C. elegans. We
describe the neural circuit for 5-HT-mediated fat loss and
show that 5-HT signaling requires Oct synthesis via tbh-1 in
the RIC neurons and that Oct administration itself is capable of
eliciting body fat loss. Oct-induced fat loss, in turn, requires
5-HT synthesis via tph-1. Combined serotonergic and octopami-
nergic signaling has a synergistic effect on body fat loss. Thus,
integrated 5-HT andOct signaling in the nervous system function
in a positive regulatory loop to promote distal fat loss. Down-
stream of Oct production, the octopaminergic ser-6 GPCR in
the AWB sensory neurons is required for 5-HT-mediated fat
loss. Previous studies have shown that the RIC and AWB neu-
rons, two major components of the serotonergic fat loss neural
circuit, are both sites of integration of sensory cues. RIC neurons
integrate long-term food deprivation and stress signals via the
TGF-beta receptor daf-1, which also controls fat and feeding in
C. elegans (Greer et al., 2008). AWB neurons sense aversive
olfactory cues and promote behavioral avoidance responses
(Bargmann, 2006). The identification of the RIC and AWB neu-
rons as key components of the serotonergic fat loss circuit sug-
gests that 5-HT signaling can be fine-tuned based on information
from the environment. Interestingly, we find that loss of the octo-
paminergic ser-6 GPCR decreases tph-1 levels and 5-HT pro-
duction in the ADF chemosensory neurons but that exogenous
Oct administration does not alter tph-1 expression, suggesting
that Oct signaling acts as a permissive, rather than instructive,
signal to promote 5-HT signaling in the nervous system. The
invertebrate Oct and the vertebrate adrenaline have many func-
tional similarities in regulating organismal stress responses and
promoting fat loss and differ in their chemical structure only by
a single hydroxyl group. Recent studies in mice have also shown
that brain-derived 5-HT regulates sympathetic tone (Yadav et al.,
2009). We contemplate whether the necessity of Oct in promot-
ing 5-HT signaling may underlie the widely noted potent fat loss
effects of the combined adrenergic and serotonergic drugs
sibutramine and fen-phen (now off the market) in humans (Cuel-Cell Mlar et al., 2000; Fangha¨nel et al., 2000; Talbot et al., 2010; Wong
et al., 2012).
Our neural circuit analyses show that 5-HT synthesis in ADF
chemosensory neurons regulates fat loss. Of the neurons in
which 5-HT is synthesized, only the ADF chemosensory neurons
have ciliated endings that are exposed to the environment. 5-HT
production in the ADF chemosensory neurons is regulated by
food availability and pathogenic bacteria (Cunningham et al.,
2012; Zhang et al., 2005), suggesting that the regulation of
5-HT-driven fat loss may, in part, be dictated by these factors.
Downstream of the ADF neurons, 5-HT signaling requires the
function of the mod-1 5-HT-gated channel in the URX body
cavity neurons. The URX neuron pair along with the AQR and
PQR body cavity neurons are best known for their role in oxygen
sensing and aerotaxis (Cheung et al., 2005; Gray et al., 2004)
and, more recently, in body size regulation (Mok et al., 2011).
In light of our studies showing a role for the URX neurons in the
control of 5-HT-mediated body fat loss and studies indicating
a general role for these neurons in controlling body fat stores
(our unpublished observations), they likely function in a more
important capacity than previously appreciated. We propose
that the body cavity neurons function as homeostatic sensors:
they integrate sensory information from both external sensory
circuits and internal states and relay signals to govern behavioral
and metabolic outcome. Notably, the body cavity neurons share
the unique anatomical feature of having cell bodies and neurites
that are exposed to the coelomic fluid, which constitutes the
circulatory fluid of C. elegans (White et al., 1986). Because the
intestine and other fat tissues are not directly innervated, our
demonstration of the role of these neurons in regulating body
fat allows for a neuroanatomical basis for communication
between the nervous system and metabolic tissues.
The neural circuitry underlying 5-HT-mediated fat loss sug-
gests that, rather than 5-HT itself, undiscovered downstream
neuroendocrine signals are relayed to peripheral metabolic
tissues to control fat loss. An important step that precedes the
discovery of such signaling molecules is the identification of
regulatory genes that dictate fat loss in the periphery, in part to
provide robust in vivo readouts of metabolic state. To this end,
we use RNAi-based screening approaches and identify two
regulators of serotonergic fat loss that function in distal meta-
bolic tissues where body fat is metabolized: the conserved
triglyceride lipase atgl-1 and the nuclear hormone receptor
nhr-76. We show that 5-HT functions as an instructive modulator
of body fat: excess 5-HT increases atgl-1 expression, which de-
creases body fat, whereas loss of 5-HT decreases atgl-1 expres-
sion and increases body fat. We found that the 5-HT-mediated
transcriptional increase of atgl-1 requires the nuclear hormone
receptor nhr-76. nhr-76 is also expressed in the intestine, and
our data indicate that loss of nhr-76 function abrogates 5-HT-
mediated fat loss by preventing atgl-1 upregulation. nhr-76
bears the highest sequence similarity to the mammalian RXR
family of nuclear receptors, well studied for their role as hetero-
dimeric partners in the regulation of fat metabolism (Germain
et al., 2006; Mangelsdorf and Evans, 1995). Although we do
not yet know whether nhr-76 forms heterodimers with other
C. elegans nuclear receptors, we note that nhr-76 has sequence
homology to the heterodimerization domain of the RXR recep-
tors (greater than 65% identity). In addition, we identified twoetabolism 18, 672–684, November 5, 2013 ª2013 Elsevier Inc. 681
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A 5-HT Neuroendocrine Circuit for Body Fat Controlputative RXR/nhr-76 binding sites within 1.2 kb of the C. elegans
atgl-1 start site. Further studies of regulation of C. elegans atgl-1
by nhr-76 may reveal new and conserved functions in fat
metabolism.
Especially interesting is our observation that the inactivation of
mod-1, selectively in the URX body cavity neurons, prohibits the
increased expression of the intestinal atgl-1 lipase and concom-
itant fat loss during serotonergic activation. This result provides
evidence for the existence of undiscovered endocrine signals
that originate in the URX neurons in response to neural 5-HT.
Such signals are likely relayed via the coelomic fluid to the intes-
tine in which body fat is metabolized. Collectively, our findings
establish a neuroendocrine axis in which an integrated neural
5-HT and Oct neural circuit regulates body fat via a long-range
endocrine signal.
EXPERIMENTAL PROCEDURES
C. elegans Culturing and Strains Used in the Study
C. elegans were cultured as described (Brenner, 1974). N2 Bristol, obtained
from the Caenorhabditis Genetic Center (CGC), was used as the wild-type
reference strain. The strains used in the study are: MT9455 tbh-1(n3247)X,
VC224 octr-1(ok371)X, RB1631 ser-3(ok2007)I, KQ1048 ser-6(tm2146)IV,
RB1690 ser-2(ok2103)X, FX1846 tyra-2(tm1846)X, VC125 tyra-3(ok325)X,
SSR857 ser-6(tm2146);tbh-1(n3247), MT15434 tph-1(mg280)II, SSR861 ser-
6(tm2146);tph-1(mg280), CX3937 lim-4(ky403)X, MT9668 mod-1(ok103)V,
SSR346 mod-1(ok103);ser-6(tm2146), and integrated transgenic strains
GR1366 tph-1::GFP, SSR747 ser-6(tm2146);tph-1::GFP, SSR647 atgl-
1::GFP, and SSR781 tph-1(mg280);atgl-1::GFP. For all experiments, animals
were synchronized by hypochlorite treatment, after which hatched L1 larvae
were plated. All experiments were conducted on day 1 adults.
RNAi
RNAi experiments were conducted as described (Srinivasan et al., 2008).
5-HT and Oct Treatment
5-HT was administered as described (Srinivasan et al., 2008). For Oct treat-
ment, 0.2 M stock Oct solution using 0.1 M HCl as a vehicle was added to
plates to reach the desired final concentration.
Oil Red O Staining
Oil red O staining was conducted as described (Yen et al., 2010), with the
following changes. Before the fixation step, worms were kept on ice for
10 min to stop pharyngeal activity. After the fixation step, worms were taken
through three freeze-thaw cycles. The working solution of the oil red O stain
(40% water:60% oil red O in isopropanol) was protected from light on a
rotating rack for approximately 1.5–2 hr before use. In each tube, 500 ml oil
red O solution was added to a 50 ml suspension of fixed worms in 60% isopro-
panol. For all genotypes and conditions tested, approximately 2,000 animals
were fixed, stained, and visually examined. Animals (20–40) were imaged using
an AxioCamMRm 12-bit digital camera, and all experiments were repeated at
least three times.
Image Acquisition and Quantitation
Black and white as well as fluorescent images of oil-red-O-stained worms
were captured using a 103 objective on a Zeiss Axio Imager microscope.
The black and white oil red O images were quantified using ImageJ software
(NIH). In all cases, lipid droplet staining in the first four pairs of intestinal cells
was quantified. Within each experiment, 10–15 animals from each condition
were quantified. All reported results were consistent across biological
replicates.
Anti-5-HT Immunostaining
Anti-5-HT immunostaining was conducted as described (Zhang et al.,
2005).682 Cell Metabolism 18, 672–684, November 5, 2013 ª2013 ElsevierCloning and Transgenic Strain Construction
Promoters and genes were cloned using standard PCR techniques from N2
Bristol worm lysates and cloned using Gateway Technology (Life Technolo-
gies). Promoter lengths were determined based on functional rescue and are
available upon request. All rescue plasmids were generated using either
polycistronic GFP or mCherry. Transgenic strains were constructed by micro-
injection in the C. elegans germline followed by visual selection of transgenic
animals under fluorescence. For the microinjections, 10–30 ng/ml of the
desired plasmid was injected with 10–20 ng/ml of an unc-122::GFP coinjection
marker and 50–80 ng/ml of an empty vector to maintain a total injection mix
concentration of 100 ng/ml. In each case, 10–20 stable transgenic lines were
generated. Two lines were selected for experimentation based on consistency
of expression and transmission rate.
Statistical Analyses
Data were analyzed for significance using Student’s t test. Error bars
represent SEM.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
five figures, and three tables and can be found with this article online at
http://dx.doi.org/10.1016/j.cmet.2013.09.007.
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